Short communication: selective cytotoxicity of curcumin on osteosarcoma cells compared to healthy osteoblasts
Run Chang,1 Linlin Sun,1 Thomas J Webster1,21Department of Chemical Engineering, Northeastern University, Boston, MA, USA; 2Center of Excellence for Advanced Materials Research, King Abdulaziz University, Jeddah, Saudi ArabiaAbstract: Curcumin is a natural phenolic compound extracted from the plant...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8b8191cc7a624eaeb13ada6eaf940930 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8b8191cc7a624eaeb13ada6eaf940930 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8b8191cc7a624eaeb13ada6eaf9409302021-12-02T02:06:53ZShort communication: selective cytotoxicity of curcumin on osteosarcoma cells compared to healthy osteoblasts1178-2013https://doaj.org/article/8b8191cc7a624eaeb13ada6eaf9409302014-01-01T00:00:00Zhttp://www.dovepress.com/short-communication-selective-cytotoxicity-of-curcumin-on-osteosarcoma-a15487https://doaj.org/toc/1178-2013 Run Chang,1 Linlin Sun,1 Thomas J Webster1,21Department of Chemical Engineering, Northeastern University, Boston, MA, USA; 2Center of Excellence for Advanced Materials Research, King Abdulaziz University, Jeddah, Saudi ArabiaAbstract: Curcumin is a natural phenolic compound extracted from the plant Curcuma longa L. In previous studies, curcumin has been shown to have anticancer, antioxidant, and anti-inflammatory effects. In this study, the cytotoxicity of different concentrations (5, 10, 25, 50, 75, and 100 µM) of curcumin dissolved in dimethyl sulfoxide was compared between MG-63 osteosarcoma and healthy human osteoblast cells. Consequently, the viability of osteosarcoma cells was less than 50% at a concentration of 10 µM compared to the control sample without curcumin, but healthy osteoblast cells had at least 80% viability throughout all the concentrations tested. The results demonstrated that MG-63 osteosarcoma cells were much more sensitive in terms of cytotoxicity to curcumin, while the healthy human osteoblasts exhibited a higher healthy viability after 24 hours of curcumin treatment. Therefore, this study showed that at the right concentrations (5 µM to 25 µM), curcumin, along with a proper nanoparticle drug delivery carrier, may selectively kill bone cancer cells over healthy bone cells.Keywords: curcumin, osteosarcoma, human osteoblast, viability, bone cancerChang RSun LWebster TJDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2014, Iss Issue 1, Pp 461-465 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine (General) R5-920 |
spellingShingle |
Medicine (General) R5-920 Chang R Sun L Webster TJ Short communication: selective cytotoxicity of curcumin on osteosarcoma cells compared to healthy osteoblasts |
description |
Run Chang,1 Linlin Sun,1 Thomas J Webster1,21Department of Chemical Engineering, Northeastern University, Boston, MA, USA; 2Center of Excellence for Advanced Materials Research, King Abdulaziz University, Jeddah, Saudi ArabiaAbstract: Curcumin is a natural phenolic compound extracted from the plant Curcuma longa L. In previous studies, curcumin has been shown to have anticancer, antioxidant, and anti-inflammatory effects. In this study, the cytotoxicity of different concentrations (5, 10, 25, 50, 75, and 100 µM) of curcumin dissolved in dimethyl sulfoxide was compared between MG-63 osteosarcoma and healthy human osteoblast cells. Consequently, the viability of osteosarcoma cells was less than 50% at a concentration of 10 µM compared to the control sample without curcumin, but healthy osteoblast cells had at least 80% viability throughout all the concentrations tested. The results demonstrated that MG-63 osteosarcoma cells were much more sensitive in terms of cytotoxicity to curcumin, while the healthy human osteoblasts exhibited a higher healthy viability after 24 hours of curcumin treatment. Therefore, this study showed that at the right concentrations (5 µM to 25 µM), curcumin, along with a proper nanoparticle drug delivery carrier, may selectively kill bone cancer cells over healthy bone cells.Keywords: curcumin, osteosarcoma, human osteoblast, viability, bone cancer |
format |
article |
author |
Chang R Sun L Webster TJ |
author_facet |
Chang R Sun L Webster TJ |
author_sort |
Chang R |
title |
Short communication: selective cytotoxicity of curcumin on osteosarcoma cells compared to healthy osteoblasts |
title_short |
Short communication: selective cytotoxicity of curcumin on osteosarcoma cells compared to healthy osteoblasts |
title_full |
Short communication: selective cytotoxicity of curcumin on osteosarcoma cells compared to healthy osteoblasts |
title_fullStr |
Short communication: selective cytotoxicity of curcumin on osteosarcoma cells compared to healthy osteoblasts |
title_full_unstemmed |
Short communication: selective cytotoxicity of curcumin on osteosarcoma cells compared to healthy osteoblasts |
title_sort |
short communication: selective cytotoxicity of curcumin on osteosarcoma cells compared to healthy osteoblasts |
publisher |
Dove Medical Press |
publishDate |
2014 |
url |
https://doaj.org/article/8b8191cc7a624eaeb13ada6eaf940930 |
work_keys_str_mv |
AT changr shortcommunicationselectivecytotoxicityofcurcuminonosteosarcomacellscomparedtohealthyosteoblasts AT sunl shortcommunicationselectivecytotoxicityofcurcuminonosteosarcomacellscomparedtohealthyosteoblasts AT webstertj shortcommunicationselectivecytotoxicityofcurcuminonosteosarcomacellscomparedtohealthyosteoblasts |
_version_ |
1718402718204166144 |